Genetics
Showing 1-31 of 31 Results
-
Paul Cabellon
Affiliate, Genetics
BioPaul is a career storyteller and brand development expert with an uncanny ability to build bridges between cultures, industries and the technologies that shape them.
His experience spans emerging technological areas in AI, national security, bioterrorism, nanotechnology, aerospace, autonomous transportation and global development. He is currently the Sr. Director of External Communications for space-based intelligence company BlackSky.
Paul previously led all brand, marketing and communications for Bill Gates’ Global Good technology invention fund at private equity firm Intellectual Ventures. He has created and led the execution of award-winning integrated communications campaigns, including two SABRE Awards, for Fortune 100 clients at PR agencies Grayling and Waggener Edstrom. Paul was the communications lead for various stealth fighter and drone sensor programs at Northrop Grumman, including the F-35, F-22 and Global Hawk programs.
He began his public relations career as a U.S. Marine Officer attaining the rank of Captain and led all publicity efforts for numerous crisis incidents including the 2001 Anthrax attack on the U.S. Capitol. He is a graduate of the Defense Information School at Fort Meade, Maryland, the strategic marketing executive program at The Booth School of Business at the University of Chicago, and received an M.A. in Communications from Johns Hopkins University. Paul completed his undergraduate studies at the University of Washington, receiving a B.A. in International Studies as well as an additional B.A. in Comparative History of Ideas.
Paul serves as a board member and trustee at the Museum of History and Industry in Seattle, Washington, and is an advisor for the NATO DIANA and Defense Innovation Unit startup accelerator programs. Paul is a research fellow at Stanford University exploring the intersection of agentic AI, national security and behavioral intent. He is an avid tennis player and enjoys spending time in nature with his family in the Pacific Northwest. -
Michele Calos
Professor of Genetics, Emerita
Current Research and Scholarly InterestsMy lab is developing innovative gene and stem cell therapies for genetic diseases, with a focus on gene therapy and regenerative medicine.
We have created novel methods for inserting therapeutic genes into the chromosomes at specific places by using homologous recombination and recombinase enzymes.
We are working on 3 forms of muscular dystrophy.
We created induced pluripotent stem cells from patient fibroblasts, added therapeutic genes, differentiated, and engrafted the cells. -
MaryAnn Campion
Professor (Teaching) of Genetics
Current Research and Scholarly InterestsMy primary research interests include 1) genetics education, 2) genetic counseling access, service delivery, and psychosocial assessment, 3) professional development, faculty vitality, and burnout.
-
Howard Y. Chang, MD, PhD
Virginia and D. K. Ludwig Professor of Cancer Research, Professor of Genetics and, by courtesy, of Pathology
On Leave from 12/16/2024 To 12/15/2026Current Research and Scholarly InterestsOur research is focused on how the activities of hundreds or even thousands of genes (gene parties) are coordinated to achieve biological meaning. We have pioneered methods to predict, dissect, and control large-scale gene regulatory programs; these methods have provided insights into human development, cancer, and aging.
-
Mike Cherry
Professor (Research) of Genetics, Emeritus
Current Research and Scholarly InterestsMy research involves identifying, validating and integrating scientific facts into encyclopedic databases essential for research and scientific education. Published results of scientific experimentation are a foundation of our understanding of the natural world and provide motivation for new experiments. The combination of in-depth understanding reported in the literature with computational analyses is an essential ingredient of modern biological research.
-
Stanley N. Cohen, MD
Kwoh-Ting Li Professor in the School of Medicine, Professor of Genetics and of Medicine
On Partial Leave from 06/04/2025 To 07/16/2026Current Research and Scholarly InterestsWe study mechanisms that affect the expression and decay of normal and abnormal mRNAs, and also RNA-related mechanisms that regulate microbial antibiotic resistance. A small bioinformatics team within our lab has developed knowledge based systems to aid in investigations of genes.
-
Le Cong
Associate Professor of Pathology (Pathology Research) and of Genetics
Current Research and Scholarly InterestsOur lab develops gene-editing technologies like novel CRISPR systems and large gene insertion techniques for gene and cell therapy. We also leverage these gene-editing tools for single-cell functional screening to probe mechanisms of cancer, immunological, and aging-associated diseases. To accelerate our work, we integrate AI and machine learning to design and evolve therapeutic RNAs/proteins, and build AI-XR co-scientists like LabOS that bridge AI computation and biomedical experimentation.
-
David Cox
Assistant Professor of Genetics and, by courtesy, of Medicine (Hematology)
BioDavid Cox is an Assistant Professor of Genetics and by courtesy of Medicine (Hematology) at Stanford University and Principal Investigator of the Cox Lab (coxlab.bio), which is opening in July 2025. He is also a ChEM-H Institute Scholar and Chan Zuckerberg Biohub Investigator.
He completed his undergraduate studies in biology at Stanford University, where he worked with Irving Weissman on understanding how the innate immune system recognizes cancer cells. He then entered the Harvard-MIT MD-PhD program, earning his MD from the Harvard-MIT program in Health Sciences and Technology (HST) and his PhD in biology from MIT. His doctoral dissertation with Feng Zhang focused on the discovery and development of CRISPR-Cas enzymes as novel DNA and RNA editing tools. During his final year of medical school, he worked as a visiting scientist with David Baker, where he initiated efforts to design sequence-specific DNA binding proteins de novo.
Following medical school, Cox completed internal medicine residency and a clinical fellowship in hematology at Stanford, where he concurrently conducted postdoctoral research in Rhiju Das's lab. In the Das lab, he fine-tuned large language models for RNA structure prediction and developed new methods for highly multiplexed detection of RNA-protein interactions.
His current list of publications and patents is available here: https://scholar.google.com/citations?user=ZohHoFYAAAAJ&hl=en&oi=ao -
Christina Curtis
RZ Cao Professor and Professor of Genetics
Current Research and Scholarly InterestsThe Curtis laboratory for Cancer Computational and Systems Biology is focused on the development and application of innovative experimental, computational, and analytical approaches to improve the diagnosis, treatment, and early detection of cancer.
